The global sequencing consumables market size is expected to reach USD 55.62 billion by 2033, expanding at a CAGR of 23.49% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growing emphasis on genomic research is the prime factor that drives the market growth. Genomic research provides insights into the genetic base of diseases, enabling the development of more precise diagnostic tools and treatments. This facilitates personalized medicine, where therapies are tailored to an individual's genomic profile, resulting in better treatment outcomes and reduced adverse effects. In December 2022, the UK government allocated around $184 million in funding to develop the most advanced genomic healthcare system worldwide, to improve health outcomes and save lives.
Owing to such a high output of genomic research, researchers employ NGS technology that enables simultaneous profiling of millions of DNA fragments and delivers an enormous volume of data in a single operation. This high-throughput technology becomes essential for large-scale genomics projects. Further, with the rising demand for sequencing technologies, newer sequencing platforms necessitate specialized consumables that align with their distinct processes. This allows developers to create high-quality sequencing consumables. Consequently, as genomics research continues to expand, there has been a substantial increase in the demand for sequencing consumables.
Additionally, the rising prevalence of cancer and genetic disorders is significantly driving the overall market growth. For instance, in June 2021, the Danish National Genome Center offered genetic testing for at least 60,000 patients as part of providing more personalized treatment. This Danish initiative aims to deliver personalized medicine and genetic analyses directly to patients and provide precise diagnosis and treatment. Genetic sequencing is crucial for the accurate diagnosis of genetic diseases as it allows comprehensive analysis of an individual's genome, making it possible to identify specific genetic variants associated with inherited genomic diseases.Consumables like library preparation kits and adapters play a vital role in fragmenting and labeling genetic material, transforming it into sequencing-ready libraries.
Hence, considering the pivotal role of sequencing consumables in genetic profiling, the growing prevalence of genetic diseases has led to a notable increase in the demand for these consumables. Key players in the market are engaged in strategies such as agreements, mergers & acquisitions, partnerships, and launches, among others, to expand their global footprints and product portfolio. For instance, in May 2023, Thermo Fisher Scientific, Inc. and Pfizer have planned to expand the availability of NGS-based testing for cancer patients in global markets, aiming to enhance localized access to advanced testing for cancer diagnosis and treatment.
Request a free sample copy or view report summary: Sequencing Consumables Market Report
The cancer diagnostics segment dominated the market in 2024 with a revenue share of 26.85%, supported by the increasing need for accurate and personalized cancer care.
The hospitals and laboratories segment captured the highest revenue share in 2024 at 36.03%.
North America dominated the market, accounting for a revenue share of 52.61% in 2024.
The Asia-Pacific sequencing consumables market is expected to record the fastest CAGR of 27.25% throughout the forecast period.
Grand View Research has segmented the global sequencing consumables market on the basis of product, platform, application, end use, and region:
Sequencing Consumables Product Scope Outlook (Revenue, USD Million, 2021 - 2033)
Kits
DNA Library Preparation
RNA Library Preparation
Target enrichment
Library quantification
Purification & quality control
Others
Reagents
Sample Prep
Library preparation and amplification
Sequencing
Accessories
Collection tubes
Plates
Others
Sequencing Consumables Platform Outlook (Revenue, USD Million, 2021 - 2033)
1st Generation sequencing Consumables
2nd Generation sequencing Consumables
3rd Generation sequencing Consumables
Sequencing Consumables Application Outlook (Revenue, USD Million, 2021 - 2033)
Cancer Diagnostics
Infectious Disease Diagnostics
Reproductive Health Diagnostics
Pharmacogenomics
Agrigenomics
Others
Sequencing Consumables End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical and biotechnology companies
Hospitals and laboratories
Academic research institutes
Others
Sequencing Consumables Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Sequencing Consumables Market
F. Hoffmann-La Roche Ltd
QIAGEN.
Agilent Technologies
Millipore Sigma
Takara Bio Inc
Beckman Coulter, Inc
Eurofins Genomics
Oxford Nanopore Technologies Ltd
Thermo Fisher Scientific, Inc
BGI Genomics
"The quality of research they have done for us has been excellent..."